Imagine…

One-Hour Infection Detection at the Point-of-Care

Pathogen Identification & Phenotypic
Antimicrobial Testing

GeneCapture has developed a portable technology solution for pathogen identification and antibiotic susceptibility testing known as The CAPTURE Platform™. See how it works in this 100-second video.

The GeneCapture Platform

Get Actionable Answers

Fast

  • Identify pathogen in one hour

  • Identify antibiotic susceptibility in two hours

Easy

  • Sample: Blood, urine, swab, or saliva

  • Portable, works in any environment

  • No refrigeration, no lab equipment, and no technical training required

Accurate

  • Highly specific and sensitive

  • Large on-cartridge library of pathogen probes

  • Pathogen X

The CAPTURE Platform

Portable Technology for Pathogen ID
& Antibiotic Susceptibility Testing (AST)

New patented solutions are enabling a rapid ID and rapid AST. Conceived from the ground up, our scientists and engineers have developed a low-cost, instrument and integrated disposable cartridge that starts with a raw sample.

  • The sample is prepped on-board (concentrated & homogenized)

  • ID by Direct RNA Hybridization (DRH) occurs on microarray

  • CMOS imaging and deep-set algorithms report ID result

  • AST incorporates lyophilized antibiotics; stable at room temperatures

  • High-speed raw count growth measurements identify susceptibility

CAPTURE Applications

In a world where antimicrobial resistance is growing, pandemics are upon us, and 30% of battlefield wounds lead to infection, we need RAPID ANSWERS. In the Clinic, in the Community, on the Farm, or on the Battlefield, CAPTURE provides the answers you need.

Partners, Collaborators, Customers & Affiliations

Awards Won

Innovation, Business Plan, Impact.

We want to make a BIG difference on a global scale. By reducing the time it takes to identify infection and providing an Antimicrobial Susceptibility Test on-site, we will change health care. Antimicrobial drugs are life savers – but only if they are used when needed; otherwise, they weaken our bodies to future threats. We bring fast decision-making directly to the patient. Infections must be treated quickly.
— Peggy Sammon, GeneCapture CEO

Contact Us